Profile data is unavailable for this security.
About the company
Abingdon Health plc is a lateral flow contract development and manufacturing organization (CDMO). The Company develops, manufactures, and distributes diagnostic devices and provides consultancy services to businesses in the diagnostics sector. Its segments include Product sales, Contract manufacturing, and Contract development. Its customer base across industry sectors includes clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available.
- Revenue in GBP (TTM)5.34m
- Net income in GBP-2.24m
- Incorporated2008
- Employees82.00
- LocationAbingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
- Phone+44 190 440 6050
- Fax+44 190 446 2122
- Websitehttps://www.abingdonhealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genflow Biosciences PLC | 0.00 | -1.18m | 7.17m | 0.00 | -- | 3.49 | -- | -- | -0.004 | -0.004 | 0.00 | 0.0059 | 0.00 | -- | -- | -- | -48.01 | -- | -51.61 | -- | -- | -- | -- | -- | -- | -6,299.75 | 0.00 | -- | -- | -- | -35.13 | -- | -- | -- |
| ImmuPharma PLC | 69.96k | -2.99m | 8.47m | 13.00 | -- | 3.91 | -- | 121.13 | -0.0092 | -0.0092 | 0.0002 | 0.0052 | 0.0227 | -- | 0.1706 | 5,381.54 | -97.05 | -89.69 | -159.35 | -106.57 | -- | -- | -4,275.31 | -7,958.69 | -- | -2.40 | 0.00 | -- | -100.00 | -- | 53.42 | -- | 32.98 | -- |
| Cambridge Nutritional Sciences PLC | 9.05m | -3.21m | 9.40m | 91.00 | -- | 1.01 | -- | 1.04 | -0.0136 | -0.0105 | 0.0385 | 0.0391 | 0.5857 | 3.97 | 2.05 | 99,406.59 | -20.81 | -10.49 | -23.88 | -11.90 | 52.90 | 59.24 | -35.53 | -27.40 | 4.22 | -128.47 | 0.0225 | -- | -11.63 | -1.96 | -125.12 | -- | -45.83 | -- |
| Bivictrix Therapeutics PLC | 0.00 | -2.33m | 9.49m | 10.00 | -- | 2.68 | -- | -- | -0.0352 | -0.0352 | 0.00 | 0.0428 | 0.00 | -- | -- | 0.00 | -50.56 | -- | -57.49 | -- | -- | -- | -- | -- | -- | -- | 0.1267 | -- | -- | -- | -6.71 | -- | -- | -- |
| Proteome Sciences plc | 5.03m | -2.44m | 10.36m | 35.00 | -- | -- | -- | 2.06 | -0.0083 | -0.0083 | 0.017 | -0.0104 | 0.4209 | 3.89 | 3.04 | 143,657.10 | -20.45 | -1.22 | -- | -- | 32.76 | 54.53 | -48.59 | -2.20 | 0.2667 | -2.03 | 1.29 | -- | -35.37 | 10.52 | -284.38 | -- | 126.22 | -- |
| Chill Brands Group PLC | 146.62k | -3.64m | 11.14m | 2.00 | -- | -- | -- | 75.97 | -0.0142 | -0.0142 | 0.0006 | -0.0024 | 0.0319 | 0.0992 | 0.3639 | 73,310.00 | -79.21 | -72.55 | -141.46 | -105.35 | 53.05 | -- | -2,485.30 | -1,625.46 | 0.6499 | -8.48 | 1.17 | -- | -86.73 | -50.89 | 23.50 | -- | -35.95 | -- |
| Kanabo Group PLC | 813.00k | -4.66m | 11.70m | 20.00 | -- | 0.7693 | -- | 14.39 | -0.0108 | -0.0108 | 0.0019 | 0.024 | 0.047 | 8.56 | 27.10 | 40,650.00 | -26.95 | -75.82 | -28.68 | -82.57 | 23.12 | -- | -572.94 | -1,786.10 | 7.96 | -13.03 | 0.041 | -- | 726.03 | -- | -50.96 | -- | -- | -- |
| Abingdon Health PLC | 5.34m | -2.24m | 12.17m | 82.00 | -- | 6.71 | -- | 2.28 | -0.0184 | -0.0184 | 0.0439 | 0.0149 | 0.8978 | 7.67 | 4.74 | 65,170.73 | -37.55 | -51.31 | -58.04 | -79.85 | 57.35 | 33.16 | -41.82 | -139.64 | 1.59 | -- | 0.3572 | -- | 42.68 | -- | 83.77 | -- | -- | -- |
| Synairgen plc | 0.00 | -9.99m | 12.57m | 30.00 | -- | 0.7871 | -- | -- | -0.0496 | -0.0496 | 0.00 | 0.0793 | 0.00 | -- | -- | 0.00 | -41.40 | -54.75 | -48.86 | -60.72 | -- | -- | -- | -83,247.62 | -- | -- | 0.00 | -- | -- | -- | 63.74 | -- | 0.00 | -- |
| Incanthera PLC | 0.00 | -1.48m | 12.91m | 8.00 | -- | -- | -- | -- | -0.0192 | -0.0192 | 0.00 | -0.0086 | 0.00 | -- | -- | 0.00 | -373.20 | -101.74 | -- | -132.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -36.11 | -- | -- | -- |
| Genincode PLC | 1.72m | -6.73m | 13.05m | 28.00 | -- | 1.48 | -- | 7.61 | -0.0703 | -0.0703 | 0.0179 | 0.0497 | 0.168 | 16.36 | 2.88 | 61,285.71 | -65.92 | -- | -72.37 | -- | 47.55 | -- | -392.31 | -- | 5.85 | -- | 0.0632 | -- | 23.92 | -- | -34.21 | -- | -- | -- |
| Shield Therapeutics PLC | 7.21m | -46.89m | 13.69m | 28.00 | -- | 0.4604 | -- | 1.90 | -0.1549 | -0.1549 | 0.0151 | 0.038 | 0.1691 | 1.80 | 0.9805 | -- | -109.95 | -42.77 | -129.39 | -48.12 | 44.76 | 79.44 | -650.12 | -274.35 | 2.64 | -124.94 | 0.1756 | -- | 261.55 | 53.86 | -151.04 | -- | -7.68 | -- |
| Provexis plc | 598.08k | -496.59k | 14.71m | 2.00 | -- | 14.67 | -- | 24.59 | -0.0002 | -0.0002 | 0.0003 | 0.0004 | 0.6717 | 3.04 | 2.95 | 299,040.00 | -55.78 | -48.82 | -41.86 | -33.68 | 46.72 | 86.14 | -83.03 | -97.64 | 1.96 | -- | 0.00 | -- | -8.51 | 10.58 | -71.79 | -- | -- | -- |
| Destiny Pharma PLC | 0.00 | -5.66m | 17.39m | 20.00 | -- | 1.89 | -- | -- | -0.0624 | -0.0624 | 0.00 | 0.0965 | 0.00 | -- | -- | -- | -60.33 | -54.32 | -67.28 | -59.97 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.02 | -- | 35.39 | -- |
| Oncimmune Holdings PLC | 1.15m | -6.15m | 17.50m | 56.00 | -- | 26.63 | -- | 15.19 | -0.0859 | 0.0507 | 0.0159 | 0.0089 | 0.1239 | 1.08 | 0.5941 | -- | -66.15 | -- | -131.46 | -- | 68.75 | -- | -533.94 | -- | 3.75 | -1.96 | 0.8897 | -- | -- | -- | -- | -- | -- | -- |
| Verici DX PLC | 15.17k | -8.95m | 17.54m | 14.00 | -- | 2.31 | -- | 1,155.93 | -0.0525 | -0.0525 | 0.00009 | 0.0314 | 0.0013 | -- | 0.1152 | 1,011.31 | -77.76 | -- | -92.28 | -- | 84.21 | -- | -59,015.79 | -- | -- | -- | 0.0232 | -- | -- | -- | -36.94 | -- | -- | -- |
Data as of May 02 2024. Currency figures normalised to Abingdon Health PLC's reporting currency: UK Pound GBX
10.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hargreaves Lansdown Asset Management Ltd.as of 08 Sep 2023 | 10.43m | 8.57% |
| Unicorn Asset Management Ltd.as of 31 Mar 2024 | 1.93m | 1.58% |
Data from 31 Mar 2024 - 02 Apr 2024Source: FactSet Research Systems Inc.
